The Patent Cliff Is Coming: Why Commercial Market Access Vendors Must Act Now to Capitalize on Anticipated Loss of Exclusivity
Imagine this: your flagship drug, a cornerstone of your portfolio, is approaching its patent expiration date. The clock is ti…
In today’s fiercely competitive pharmaceutical landscape, the difference between market leadership and obsolescence often hinges on one thing: information. But what if your most valuable asset isn’t just your drug’s efficacy or patent status — it’s the…
What AI Knows About Your Drug vs. Your Competitors Read Post »
Don’t Get Burned: 3 Critical Patent Due Diligence Steps Before Investing in Biotech IPOs
In the high-stakes world of biotech investing, the promise of groundbreaking therapies and transformative innovations often comes with a hefty price tag—and equall…
Don’t Get Burned: 3 Critical Patent Due Diligence Steps Before Investing in Biotech IPOs Read Post »
In the fiercely competitive world of pharmaceuticals, timing isn’t just everything—it’s the difference between blockbuster success and missed opportunities. Yet, behind the scenes, a complex chess game unfolds, where companies strategically extend pate…
Unlocking Innovation: How Hard Data Is Breaking Down the Patent Wall in Pharma
In the high-stakes world of pharmaceuticals, patent protection is often viewed as the ultimate fortress—an impregnable wall guarding lucrative drug formulations and innovati…
Crack the Patent Wall: How Hard Data Beats Big Pharma’s IP Strategy Every Time Read Post »
In the high-stakes world of pharmaceuticals, the expiration of a patent isn’t just a milestone—it’s a potential death knell for blockbuster drugs. Once the patent clock runs out, generic competitors flood the market, often slashing prices and eroding p…
Five Plays That Keep Your Blockbuster Drug Alive After the Patent Clock Runs Out Read Post »
Unmasking the Hidden Tactics of Evergreening: How Patent Strategies Are Extending Drug Exclusivity Beyond Innovation
In the high-stakes world of pharmaceuticals, innovation is supposed to be the driving force behind new treatments and cures. But what h…
In the high-stakes world of pharmaceuticals, innovation is often viewed through the lens of new drug development, hefty R&D budgets, and regulatory hurdles. But what if the real treasure trove lies not in the next big blockbuster, but in the overlo…
Expired and Abandoned Drug Patents: The Hidden Goldmine Everyone Ignores Read Post »
In the high-stakes world of biopharma, timing isn’t just everything—it’s the difference between riding a wave of growth or being left behind as the tide recedes. As the industry faces mounting pressures—from patent cliffs to accelerating innovation—equ…
Sell Before the Cliff Drops: A BD Playbook for Biopharma Equipment Suppliers Read Post »
In the fast-paced world of pharmaceuticals, timing is everything. When a blockbuster drug’s patent expires, it opens the floodgates for generic competition, dramatically altering market dynamics and profit margins. Yet, for many pharma executives and i…
Track Global Drug Patent Expiry by Geography — Without Hiring a Team of Analysts Read Post »